Pyridoxine

CHEMBL1364 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
169.2 g/mol
LogP
-0.8
Phase
4

Pyridoxine (vitamin B6) is a water-soluble vitamin that is converted to its active coenzyme forms pyridoxal-5-phosphate (PLP) and pyridoxamine-5-phosphate, which serve as essential cofactors for over 100 enzymatic reactions in amino acid metabolism, neurotransmitter synthesis, and glycogen catabolism. It is used therapeutically for pyridoxine deficiency states, isoniazid-induced neuropathy, pyridoxine-dependent epilepsy, and nausea of pregnancy.

Khối lượng phân tử

169,1800 g/mol

LogP

-0,80

TPSA

73,60 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ncc(CO)c(CO)c1O

InChI

InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3

Molecular Formula

C8H11NO3

HBD / HBA

3 / 4

Liên kết có thể quay

2

Nguyên tử nặng

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Pyridoxine (vitamin B6) is a water-soluble vitamin that is converted to its active coenzyme forms pyridoxal-5-phosphate (PLP) and pyridoxamine-5-phosphate, which serve as essential cofactors for over 100 enzymatic reactions in amino acid metabolism, neurotransmitter synthesis, and glycogen catabolism. It is used therapeutically for pyridoxine deficiency states, isoniazid-induced neuropathy, pyridoxine-dependent epilepsy, and nausea of pregnancy.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Pyridoxine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1364. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1054. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.